Concert Pharmaceuticals, Inc (CNCE) Covered Calls

Concert Pharmaceuticals, Inc covered calls Concert Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged indeuterium chemistry to discover and develop drug products that have impact for patients and address important medical needs.

You can sell covered calls on Concert Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CNCE (prices last updated Tue 4:16 PM ET):

Concert Pharmaceuticals, Inc (CNCE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.87 -0.80 10.24 15.60 304K - 0.0B
Covered Calls For Concert Pharmaceuticals, Inc (CNCE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 12.5 0.35 15.25 -18.0% -1642.5%
Jan 18 12.5 1.05 14.55 -14.1% -160.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It discovers and develops novel small molecule drugs for renal disease, CNS disorders, inflammation and hematologic disorders. The company also creates novel medicines that address commercially important needs by applying its deuterated chemical entity platform to compounds with well-characterized pharmacological activity. Concert Pharmaceuticals was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.